chrisvoncsefalvay/vaers-outcomes huggingface dataset:
For unknown reason (not documented in chart) patient received the first Moderna COVID-19 Vaccine dose on 1/27/22 and the second dose of Moderna COVID-19 Vaccine on 2/17/22 which is earlier than 28 days and outside of the 4-day grace period. There were no adverse events associated with administration of the vaccine. Per CDC guidance, doses inadvertently administered earlier than the grace period should not be repeated.
pt. passed out few minutes after receiving his first dose of vaccine.   denies any past medical history.   no history of allergic reaction.  First set of V/S :   BP 142/76, R 20, P68, O2Sat 96%, BS 94.   Pt. monitored for 20 mins with next set of V/S:  BP 133/83, P 74, R 18, O2 Sat 98%.  Pt. verbalized feeling better by the time he left he parking lot.  Advice pt. to eat and drink before coming for the next dose, and also to follow up with PCP if symptoms reoccurs.
1825 Pt received the Pfizer vaccine. Patient sat in chair being monitored for 15 minutes. At 1832 pt felt lightheaded and fainted, emergency response CALLED. Patient appeared pale and diaphoretic. RNs assisted patient down to the floor with head supported with jacket and legs elevated. 1837 Patient's vital signs BP: 101/59, HR: 60, o2: 97%. Patient woke up stating that she is ok. Emergency response arrived 1838. Continued to monitor patient, @ 1845 BP: 110/71, HR: 64, o2:98%. Pt states feeling better, offered juice, pt able to tolerate 1 cup of apple juice with no complications.  1850 patient states feeling better, assisted patient to sitting position from lying down. VS obtained BP: 96/57, HR: 72, o2: 97%. Emergency response recommended patient to to the Emergency Department, but patient refused. States that she is going to go home. Advised that she call for a ride, and patient agreed. 1855 Assisted patient in the standing position, BP: 99/63, HR: 65, o2: 96%. Pt was able to tolerate more apple juice, denies any lightheaded, dizziness or headache. Patient stated that her ride was on the way. Patient agreed and continued to be monitored for another 15 minutes. Pt discharged @ 1915 in stable condition.
Patient received Moderna vaccine at the age of 17y by mistake.  Patient was monitored for 15 minutes per policy with no problems noted.  When accidental dosage was caught, patient was called to inform and patient had no complaints.  No adverse effects noted.
This spontaneous report was received from a pharmacist refers to a female patient of unknown age. On 06-MAR-2013, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot # not reported), 0.5 ml, intramuscularly. Concomitant therapies included PREVNAR 13 on 06-MAR-2013. On an unknown date in March 203, the patient experienced pain in the injection site where the PNEUMOVAX 23 was administered. The injection site was still hurting 2 days later and the patient could not lift her arm above her head. She had applied ice but has not seen her physician. No laboratory tests were performed. The outcome of pain in the injection site was unknown. This is one of 2 reports received from the same source. Additional information is not expected.
Experienced chills, fever, sick to stomach feeling, nausea, blurry vision for two days. Did not seek medical attention. Symptoms diminished in 3 days.
patient states on day of just felt "normal tired".  The next day 1/26/21,  patient was at lunch at about 1300 and has " high heartrate around  120-130 beats /minute" .  Patient is a healthcare professional.   States took some deep breaths and seemed to help.  patient denied chest pain, no irregular heartrate,, no shortness of breath,  no rash or redness to injection  site or body.  , no fever,   Today at work took pulse at about 0930am and heartrate was 74 beats /minute.  No other symptoms reported at this time.  Patient is currently at work and states will clock out soon due to symptoms.  Patient educated to report to  ER if worsening symptoms, importance of follow up with pcp , and educated on reported system.  Verbalized understanding.
5 minutes after injection, fogginess and sleepy. Sort of like being drunk. Did not want to talk. Lethargy and weakness. High BP.  This was a much shorter time than after 1st one.  Next day:  left arm/hand/fingers had uncontrollable muscle movements, beginning about 9:30 am.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. It was reported that on an unknown date in January 2013 and on 12-JUN-2013 the patient was vaccinated with a first and a second doses of GARDASIL (doses, lot numbers and route was not reported) respectively. No adverse event reported. Additional information has been requested.
10Oct89 pt vax w/ double dose of hepta B; devel muscle aches, severe h/a, arthralgia. Missed 5 days of work.  Tx w/ Orudis.
Rapid heart Rate that began about 12 hours after the injection.  Heart rate of 123 all night and went to ER next morning after calling Nurse on Call system.  I was admitted and the Dr ordered bag after bag of fluids to and kept me in the unit overnight for observation.  Did may hear tests (EKG, ECHO STRESS,CTA chest) and results all came back good.  I was released on 1/19/21 at 2pm  and my hear rate is back to normal (82 bpm).
This case was reported by a other health professional via call center representative and described the occurrence of feeling unwell in a 50-year-old female patient who received FLUARIX QUADRIVALENT (batch number 4Z42R, expiry date 3-th June 2017). Concurrent medical conditions included drug allergy (drug allergy to LEVAQUIN, bee stings and Penicillin). Concomitant products included vitamin D and EVAMIST. On 25th October 2016, the patient received FLUARIX QUADRIVALENT .5 ml. On 25th October 2016, less than an hour after receiving FLUARIX QUADRIVALENT, the patient experienced feeling unwell, skin swelling, itchy skin, erythema, swollen tongue and throat constriction. On 26th October 2016, the patient experienced skin irritation, injection site erythema and injection site swelling. The patient was treated with prednisone and antihistamines. In October 2016, the outcome of the swollen tongue and throat constriction were recovered/resolved. On an unknown date, the outcome of the feeling unwell, skin swelling, itchy skin, erythema, skin irritation, injection site erythema and injection site swelling were not recovered/not resolved. The reporter considered the feeling unwell, skin swelling, itchy skin, erythema, swollen tongue, throat constriction, skin irritation, injection site erythema and injection site swelling to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: This case was reported by the patient, who was a physican therapist at a hospital. The patient had an allergy to Penicillin, bee stings and LEVAQUIN but the patient had no allergy to eggs. The patient received Influenza vaccine Quadrivalent 2016-2017 season around lunch time on the left upper arm. Within 45 minutes after vaccination, the patient starting feeling sick and then she experienced itchy, swollen and red skin. Her tongue swelled up and she was taken to the emergency room near the physical therapy area. The patient was treated with 60 mg of Prednisone for the next 5 days and an antihistamine Tepcid. On this morning the patient was woke up, and the patient was beat red on her chest, arms and back On same day the patients experienced swollen tongue, throat constriction. On 26th October 2016, the patient experienced skin feels raw and the injection site was all red and puffy. Her throat swelling and closing up was resolved after treatment at the hospital but she had still experiencing her other side effects.
felt blisters around the mouth and roof of mouth/breaking up in blisters/ filled with a clear fluid in her mouth; if the blisters are in her throat and that might give her this different voice; breaking up in blisters, that are filled with a clear fluid in her lips; headache the 3rd and 4th day; the day after the vaccine she was very very sleepy, could not keep her eyes opened; severe body pains; This spontaneous case was reported by a consumer and describes the occurrence of ORAL MUCOSAL BLISTERING (felt blisters around the mouth and roof of mouth/breaking up in blisters/ filled with a clear fluid in her mouth), DYSPHONIA (if the blisters are in her throat and that might give her this different voice), LIP BLISTER (breaking up in blisters, that are filled with a clear fluid in her lips), SOMNOLENCE (the day after the vaccine she was very very sleepy, could not keep her eyes opened) and PAIN (severe body pains) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045J21A, 021C21A and 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESTRADIOL (ESTROGEN) for an unknown indication.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, the patient experienced SOMNOLENCE (the day after the vaccine she was very very sleepy, could not keep her eyes opened) and PAIN (severe body pains). On 05-Dec-2021, the patient experienced ORAL MUCOSAL BLISTERING (felt blisters around the mouth and roof of mouth/breaking up in blisters/ filled with a clear fluid in her mouth), DYSPHONIA (if the blisters are in her throat and that might give her this different voice), LIP BLISTER (breaking up in blisters, that are filled with a clear fluid in her lips) and HEADACHE (headache the 3rd and 4th day). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. On 03-Dec-2021, SOMNOLENCE (the day after the vaccine she was very very sleepy, could not keep her eyes opened) had resolved. On 05-Dec-2021, PAIN (severe body pains) had resolved. On 06-Dec-2021, HEADACHE (headache the 3rd and 4th day) had resolved. At the time of the report, ORAL MUCOSAL BLISTERING (felt blisters around the mouth and roof of mouth/breaking up in blisters/ filled with a clear fluid in her mouth), DYSPHONIA (if the blisters are in her throat and that might give her this different voice) and LIP BLISTER (breaking up in blisters, that are filled with a clear fluid in her lips) had not resolved.            This case was linked to MOD-2021-405849, MOD-2021-405859 (Patient Link).
Should not have been given at that time.  And given at the same time as PPSV23.
pt recv 2 doses of vax 24MAY96 & 8MAY96 & in 1996 lab eval revealed low seroconversion w/varicella zoster IGG titer of 0.54;
TD administered on 8/20/08.  On 8/22/08, patient presented left work and requested the RN to look at left arm.  RN returned.  Patient to apply medicine and a diagnosis of vaccine UOCLI groin.  Treated with Tylenol or Motrin.  Had a flu appt on 8/21/08.  No treatment indicated.  Patient informed by RN that his arm was red, swollen and hard to the touch when he went to the doctor's office.
Information has been received from a physician concerning a female patient who was vaccinated with her first dose of Gardasil, IM.  One week post vaccination, the patient experienced irregular menstrual period (two to three weeks earlier than scheduled).  Subsequently, the patient recovered from irregular menstrual period.  Medical attention was sought.  Patient Quality Complaints (PQC) was not involved.  No further information is available.
Employee was administered H1N1 vaccine in left deltoid on 10/28/09 and one day later she experienced swelling of her eyelids and redness around her lips. She is following up with her primary care physician. Followup attempts unsuccessful.
Presented w/ abdom. pain, n/v & h/o colon ca. 2014 and recurrent SBOs. COVID+, asymptomatic initially but later developed fever/hypoxia. Tx w/ abx, steroid-Decadron, O2
Patient received second dose of Moderna Covid vaccine at 0930 on 3/4/21 and presented to ED at 1800 on 3/4/2021 with complaint of weakness and not being able to get out of recliner.  Patient was admitted to hospital under observation stay.  The following meds were started: pantoprazole 40 mg IVP once and  normal saline at 100 mL/hr (ran for 7.5 hours = 750 mL). Patient returned back to her baseline by approximately 1400 on 3/4/21.
Severe Left Side Face Pain, tingling and numbness.  This is SEVERE., unable to touch face, anything that touches the left side inside my mouth causes pain to shoot up my face into my left eye,  and around the side of my face toward my left ear.  Left cheek pain. Jaw pain. Severe severe pain around left eye.   Severe pain trying to drink any liquids.  Hard shaking, chills and fever for days. Total face numbness. Face pain possibly like Trigeminal Neuralgia. Pain remains still. Has not gone away!!!!!
Admit Date:  8/17/2022     Discharge Date: 8/20/22     Principal Dx/ Final Dx:  Acute metabolic encephalopathy     Relevant Inpt Dx:  Principal Problem:    Acute metabolic encephalopathy  Active Problems:    Rheumatoid arthritis involving both wrists with positive rheumatoid factor    Essential hypertension           HPI:     Hospital Course:    This 84 year old man was admitted with acute metabolic encephalopathy.  It was felt to be hypertensive encephalopathy.  His BP improved and he has been doing well.  He is alert and conversant and ambulating in hall.  MRI shows chronic changes but nothing acute                 Consults:    IP CONSULT TO NEUROLOGY  IP CONSULT TO SOCIAL WORK           Disposition:  home     Discharge Condition:  fair
"Documented arm swellings with pain and redness lasting more than 3 days. Untreated." This is the 1st of two such identical documented reports from this source-no other information was provided.
prolonged syncope,  urinary incontinence, nausea, vomiting, shaking, chills. Patient took ibuprofen and began to fill better.
Found deceased on 11/14/2021. Reported to have allergic reaction/rash to 2nd dose on 03/14/2021.
Pain and numbness in arm, neck, shoulder, and back continuing for weeks after the shot was given.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old male patient received BNT162b2 (BNT162B2), on 31Mar2021 as dose 1, single (Lot number: ER8733), in left arm, on 21Apr2021 as dose 2, single (Lot number: ER8731), in left arm and on 02Nov2021 as dose 3 (booster), single (Lot number: FH8030) at the age of 58 years, in left arm for COVID-19 immunization. The patient's relevant medical history included: "high blood pressure" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19.
mild difficulty breathing; swelling lymph nodes; feels like he got the flu; nausea; pain at injection site; headache; tired; Low Appetite; This is a spontaneous report received from sponsored program , from a contactable consumer (patient's son). An 80-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry dates were not provided), via an unspecified route of administration, on an unknown date in Feb2021, as single dose for COVID-19 immunisation. After receiving the first dose of the BNT162B2, approximately in Feb2021, the patient experienced pain at injection site, headache, swelling lymph nodes, nausea, tired, mild difficulty breathing and low appetite. He also felt like he got the flu. The patient's medical history and concomitant medications were not reported. It was informed to reporter to consult HCP since his father was experiencing mild difficulty breathing which require immediate medical attention. All the other side effects except low appetite have been reported with the BNT162B2. The vaccine might vary person to person the side effects listed are not different from one dose to another. These side effects could occur with either dose. The duration of the symptoms is undetermined and asked him to consult his HCP if symptoms worsen or don't go away. No treatment was received for the events. The outcome of the events was unknown.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
Nurse stated when she administering the second dose of the Moderna vaccine to one of her patients, some of the vaccine leaked out and the patient didn't get full dose.; A spontaneous report was received from a nurse concerning a patient who received Moderna's COVID-19 Vaccine (mRNA-1273), and vaccine leaked out.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On unknown date, the patient received their second of two planned doses of mRNA-1273 (Lot number 011L20A) intramuscularly for prophylaxis of COVID-19 infection.   Nurse stated that while administering the second dose of the Moderna vaccine to one of her patients, some of vaccine leaked out and the patient didn't get full dose.   Treatment information was not provided.    Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event vaccine leaked out was not reported.; Reporter's Comments: This report refers to a case of product administration error for mRNA-1273 (Lot number 011L20A), where the vaccine leaked out during administration. There were no reported AEs associated with this case of incomplete dose administered.
The patient got her first dose on Jan 21 and was to come back for her 2nd dose on Jan28th and missed it; Case reference number US-BN-2021-000047 is a spontaneous case report initially received from a health care professional via Agency (reference number USBAV21-0048) on 04-Feb-2021, and concerns a 19-year-old adult female patient.   The patient's medical history and concomitant medication details were not provided.  On 21-Jan-2021, the patient received the first dose of RabAvert (Inactivated Rabies Virus Vaccine, Batch no. ARBA731A) at an unknown dose, administered intramuscularly and for pre-exposure prophylaxis.  On 28-Jan-2021, the patient was scheduled for the second vaccination, but it was not possible to administrate the second vaccine dose since the patient missed it (missed dose).   On 04-Feb-2021, the patient received the second dose of RabAvert (Inactivated Rabies Virus Vaccine, Batch no. ARBA571B) at an unknown dose, administered intramuscularly and for pre-exposure prophylaxis.  It was not reported if the patient experienced any adverse events due to RabAvert.  It was stated that the reporter asked regarding administration schedule: was it necessary to restart the vaccination schedule or should the vaccination be resumed. After information provided, reporter informed the patient, and stated that the vaccination schedule was resumed.   No further information was provided.; Reporter's Comments: Product dose omission issue i listed by convention. Reportedly the patient missed the second scheduled dose of Rabies vaccine and received the product within a week later, which is considered to be product dose omission issue. No adverse events were reported. Product dose omission issue is not related to the suspect product but to human action.; Sender's Comments: Product dose omission issue i listed by convention. Reportedly the patient missed the second scheduled dose of Rabies vaccine and received the product within a week later, which is considered to be product dose omission issue. No adverse events were reported. Product dose omission issue is not related to the suspect product but to human action.
This spontaneous report as received from a vendor refers to a male patient of unknown age. The patient was vaccinated with a dose of 0.5 ml PNEUMOVAX 23 (lot # reported as H00982G, expiration date February 2014) intramuscularly on an unknown date. It was reported that the patient developed redness down his back and along his chest and was hospitalized. Address, name, and phone number of the hospital were unspecified. The outcome was unknown. Additional information has been requested
I had an abnormal pap result. They sent me to see an OB/GYN, an acid treatment was done for a scrap of cells. No cancer was detected but unidentified cells were detected. I will be going back in 6 months to have my pap test repeated. THIS is the first abnormal pap test I have ever had in my life.
Do not know or think this is an adverse reaction but have not found out why these symptoms have happened. I woke up to the most severe head pain I have ever had. Took Excedrine for migraines and the pain went down a couple of hours with ice packs too.  A louder ring in my right ear started about a day later and slowly has increased with having a sensation of a plugged up ear. In addition the right side of my ear and some parts of the face have diminished sensation.
Husband had Covid after receiving the Pfizer Primary series vaccines; Husband had Covid after receiving the Pfizer Primary series vaccines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Husband had Covid after receiving the Pfizer Primary series vaccines". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results, notes: Her Husband had Covid.  Clinical course: Caller has been Exposed 2x to Covid 19 and never got it. Her Husband had Covid after receiving the Pfizer Primary series vaccines, He had a mild case but "his taste buds still weren't the same. "She mentioned her husband developed Covid after receiving all of his Covid-19 vaccines and his taste buds are still effected.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
15 minutes after shot could not raise his head up 1 1/2 hr. Jaw didn't work very good over next week. Arm + legs weak. 10/17/09 after 5 hours in emerg. room they said for his age he is in good health. They ruled out possible stroke, said they could not find any reason for problem
My health has been deteriating daily. I am now at the point where I can only function very slowly for a few minuets and have to rest.
INCORRECT DOSE ADMINISTERED; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 05-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 05-MAR-2021, the patient experienced incorrect dose administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of incorrect dose administered was not reported. This report was non-serious.
Intense angina - took 3 nitroglycerin pills (they had no effect) - reaction lasted approx 36 hours High blood pressure (175/90 av) - lasted approx 36 hours Fever (100 degree) - lasted approx 36 hours Nausea (at 7:00 am) - lasted approx 20 minutes